BioTuesdays

Titan Medical offering raises $10.5-million

Titan Medical

Titan Medical (OTCQX:TITXF; TSX:TMD) has closed a public offering of 11,670,818 units at a price of 90 cents each for gross proceeds of $10.5-million.

Each unit consists of one common share and one warrant, with each warrant exercisable to purchase an additional common shares at a price of $1 for a period of 60 months.

Net proceeds will be used to complete building in the current first quarter five first-in-human units of its SPORT Surgical System, and for working capital and other general corporate purposes.

The offering was made under an agency agreement with Bloom Burton & Co. Roth Capital Partners acted as a special selling group member in connection with the offering.

Sign up for the BioTuesdays weekly newsletter

Get the latest news on the healthcare industry’s corporate and clinical developments, executive moves, and market updates. Every Tuesday, in your inbox.